Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
112.51%
-
Total 13F principal
-
$437,645,000
-
Principal change
-
+$399,485,000
-
Total reported market value
-
$491,457,000
-
Number of holders
-
40
-
Value change
-
+$448,400,000
-
Number of buys
-
39
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q4 2015
As of 31 Dec 2015,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
40 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$437,645,000
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, Calamos Advisors LLC, UBS ASSET MANAGEMENT AMERICAS INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Invesco Ltd., and LAZARD ASSET MANAGEMENT LLC.
This page lists
40
institutional bondholders reporting positions
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.